Intermede Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$54.2M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$21.8M |
| 3 |
S&P Global
SPGI
|
+$13.3M |
| 4 |
ANSS
Ansys
ANSS
|
+$10.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$8.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$13.8M |
| 2 |
Oracle
ORCL
|
+$11.2M |
| 3 |
Biogen
BIIB
|
+$8.62M |
| 4 |
Invesco Mortgage Capital
IVR
|
+$380K |
| 5 |
AGN
Allergan plc
AGN
|
+$143K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.55% |
| 2 | Healthcare | 19.42% |
| 3 | Communication Services | 18.92% |
| 4 | Technology | 16.47% |
| 5 | Industrials | 5.54% |
Similar funds
Intermede Investment Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Intermede Investment Partners held 28 positions worth $1.25B, down 6.3% from $1.33B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Intermede Investment Partners deployed $142M of net new capital in Q4 2018, opening 2 new positions and adding to 21 existing holdings. Its largest new stake was Worldpay, Inc.: 622,838 shares worth $47.6M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Wells Fargo, an estimated $13.8M trimmed.
- Intermede Investment Partners's largest Q4 2018 buy was Worldpay, Inc.: 622,838 shares worth $47.6M.
- Intermede Investment Partners added most to S&P Global in Q4 2018, an estimated $13.3M increase.
- Intermede Investment Partners's biggest Q4 2018 reduction was Wells Fargo, cutting an estimated $13.8M.
- Intermede Investment Partners fully exited Invesco Mortgage Capital in Q4 2018, selling an estimated $380K.
- Intermede Investment Partners's ten largest holdings make up 51% of its $1.25B portfolio in Q4 2018.
- Intermede Investment Partners opened 2 new positions and closed 1 in Q4 2018.
- Intermede Investment Partners's portfolio value fell 6.3% quarter-over-quarter to $1.25B.
Based on Intermede Investment Partners's 13F filing for Q4 2018, filed 14 Feb 2019.